Related by context. All words. (Click for frequent words.) 82 Patent Lawsuit Against 80 Patent Infringement Suit 80 Patent Suit Against 79 Patent Infringement Lawsuit Against 78 Settle Patent Litigation 78 Settle Litigation 77 Patent Infringement Lawsuit 77 Wins Patent Infringement 76 Patent Infringement Litigation 76 Preliminary Injunction Against 76 Patent Lawsuit 76 Licensing Pact 76 Settles Patent 75 CFO Resigns 75 Infringement Suit 75 Announces Favorable 75 Narrows 4Q Loss 75 Files Patent Infringement 75 Settle Patent 75 Patent Infringement Case 75 Settles Litigation 75 Receives Favorable Ruling 74 Patent Dispute 74 Settles Patent Lawsuit 74 Settle Patent Dispute 74 Q1 Loss Widens 74 Board Authorizes 74 Announces Dismissal 74 Infringement Case 74 Restate Financials 74 Q2 Adj 74 Antitrust Lawsuit 74 Completes Tender Offer 74 Q4 Profit Plunges 74 Settles Dispute 74 Nasdaq Delisting Notice 73 Stock Soars 73 Purported Class 73 Q3 Loss Narrows 73 Backs FY# Outlook 73 Posts 4Q Profit 73 Plans Buyback 73 Settles Patent Litigation 73 Posts Wider Loss 73 Announces Licensing Agreement 73 Trims Loss 73 3Q Loss Widens 73 Shareholder Lawsuit 73 Terminate Merger Agreement 73 Gets Favorable 73 Q3 Loss Widens 73 Q2 Loss Widens 73 Boosts Buyback 73 Nasdaq Delisting 73 Reaffirms FY# Guidance 73 Q2 Loss Narrows 73 Million Lawsuit Against 73 Exploring Strategic Alternatives 73 Acacia Subsidiary 73 Q4 Loss Narrows 73 Q1 Loss Narrows 73 Reports Wider Loss 73 Patent Suit 73 Announce License Agreement 73 Losses Widen 73 Shareholder Suit 73 Patent Infringement Claim 72 Buyback Plan 72 Q1 Profit Soars 72 Patent Suits 72 Jumps Higher 72 Evaluate Strategic Alternatives 72 Lowers Guidance 72 Files Trademark 72 Stock Plunges 72 Suit Vs 72 Files Countersuit Against 72 Antitrust Suit 72 Analyst Upgrade 72 Universal Shelf Registration 72 Countersuit 72 Vigorously Defend 72 Files Amended 72 Ups Guidance 72 Q2 Profit Slips 72 Slashes Price 72 Annual Meeting Date 72 Posts 2Q Profit 72 Lifts FY# Outlook 72 OKs Buyback 72 Q2 Profit Soars 72 Successfully Completes Tender Offer 72 Backs FY# View 72 Buyout Bid 72 Settles Patent Dispute 72 Patent Infringement 72 Announce Settlement 72 Q4 Profit Surges 72 Q4 Loss Widens 72 KB Home Swings 71 Injunction Against 71 Reaffirms FY# Outlook 71 Guides Inline 71 Q1 Profit Plunges 71 Q3 Adj 71 Q2 Profit Plunges 71 Announce Early Termination 71 Plans Job Cuts 71 1Q Loss Widens 71 Q3 Profit Decreases 71 Posts 4Q Loss 71 Explore Strategic Alternatives 71 Shareholder Lawsuit Against 71 Receives Favorable 71 Delays Filing 71 Patent Ruling 71 Buyout Deal 71 Q4 Profit Drops 71 Trademark Lawsuit 71 Reaffirms Outlook 71 Fraud Suit 71 Settles Charges 71 4Q Loss Widens 71 Loss Shrinks 71 Q2 Profit Surges 71 Terminates Merger Agreement 71 Announce Definitive Agreement 71 Posts 1Q Profit 71 Restate Results 71 Suspends Dividend 71 #M Buyback [002] 71 Narrows Loss 71 Boosts Dividend 71 Q1 Profit Surges 71 Trademark Suit 71 Favorable Ruling 71 Restructures Debt 71 Patent Infringement Lawsuits 71 Settle Shareholder 71 Wider Loss 71 Losses Narrow 71 Signs Merger Agreement 71 Q2 Profit Drops 71 4Q Profit Surges 71 Legal Dispute 71 Proxy Fight 71 Revises FY# Outlook 71 4Q Profit Soars 71 Buyout Talks 71 Trademark Infringement Lawsuit 71 Provides Update Regarding 71 Files Patent 71 Dismiss Lawsuit 70 Proposed Buyout 70 Trims Outlook 70 Wins Summary Judgment 70 Q2 Profit Plummets 70 Q1 Adj 70 Infringes 70 2Q Loss Narrows 70 Q3 Profit Soars 70 Withdraws Offer 70 Buyout Rumors 70 Amends Agreement 70 Settles Lawsuits 70 Hikes Dividend 70 Shares Soar 70 Files Voluntary 70 Analyst Downgrade 70 Announces Early Termination 70 Registration Statement Declared Effective 70 Announces FDA Clearance 70 Receives Subpoena 70 Stock Buyback 70 Secures Financing 70 Remains Neutral 70 2Q Profit Slides 70 Shareholder Suits 70 TriCo Bancshares Announces 70 Arthritis Drug 70 Posts 3Q Loss 70 Boosts Outlook 70 Completes Merger With 70 Stockholders Approve Merger 70 Q1 Profit Jumps 70 NASDAQ Listing Requirements 70 Earnings Scorecard 70 Slashes Outlook 70 Board Unanimously Rejects 70 Completes Patient Enrollment 70 Boosts Guidance 70 Neutral Analyst Blog 70 Q3 Profit Drops 70 Trademark Dispute 70 Lawsuit Alleging 70 Closes Merger 70 Extends Tender Offer 70 4Q Profit Down 70 License Pact 70 Antitrust Settlement 70 Receives Notification 70 Strengthens Balance Sheet 70 Net Loss Widens 70 Ups Bid 70 Q1 Profit Decreases 70 CFO Resignation 70 HSR Waiting Period 70 Reports Receipt 70 Unsolicited Proposal From 70 Q3 Profit Jumps 70 Settles Claim 70 2Q Loss Widens 70 Reminds Shareholders 69 Sell Itself 69 Judge Tosses Out 69 Stock Buyback Plan 69 Pomerantz Law Firm 69 Backs FY# Guidance 69 Hostile Bid 69 Reduces Debt 69 Revises FY# Guidance 69 Files Shelf Registration Statement 69 Milestone Payment 69 Finalizes Purchase Of 69 Consummates 69 Obtains Exclusive Rights 69 Narrower Loss 69 Posts Gains 69 1st Quarter Results 69 Explores Strategic Alternatives 69 Shares Plummet 69 Biotech Firm 69 Antitrust Lawsuit Against 69 Sign License Agreement 69 Lifts FY# Guidance 69 Posts Narrower Loss 69 Lifts Dividend 69 Taro Receives 69 1Q Loss Narrows 69 Lowers FY# Outlook 69 Outlook Disappoints 69 Q4 Profit Soars 69 Completes Reverse Merger 69 Acquire Controlling Interest 69 Settle Lawsuits 69 Private Equity Buyout 69 Successfully Completes Acquisition 69 Misses Views 69 Stock Plummets 69 Amend Merger Agreement 69 Q4 Profit Slips 69 Settles Suit 69 Q3 Profit Surges 69 Provides Shareholder 69 Settles Fraud 69 Outlines Strategy 69 1Q Profit Declines 69 Provides Status 69 Announce Merger Agreement 69 Outlook Analyst Blog 69 Earnings Soar 69 Largest Shareholder 69 Restates Earnings 69 Licensing Deal 69 Delayed Filing 69 Takeover Speculation 69 Announces Definitive Agreement 69 Q2 Profit Decreases 69 Forecast Quick Facts 69 Faces Delisting 69 Expands Internationally 69 Settle Dispute 69 Settle Fraud 69 Profit Beats Expectations 69 Universal Shelf Prospectus 69 Patent Infringement Action 69 Narrows Guidance 69 Malpractice Suit 69 Lawsuit Involving 69 Lawsuit Dismissed 69 Spears Conservatorship 69 Posts 2Q 69 Resolves Dispute 69 Dividend Hike 69 Piracy Lawsuits 69 Files IND 69 Signs License Agreement 69 Gets Subpoena 69 REUTERS Christian Charisius 69 Sign Definitive Agreement 69 Billion Buyback 69 Review Strategic Alternatives 69 Withdraws Proposal 69 Commence Tender Offer 69 Shareholders Approve Merger Agreement 69 Claim Against 69 Receives CE Marking 69 Reaffirms Guidance 69 Revenue Climbs 69 Raises Buyback 69 Generic Version 69 Settle Suits 69 OxyContin Maker 69 Ups Dividend 69 Beats Forecast 69 Receives Notice Regarding 69 Q3 Profit Plunges 69 2Q Profit Surges 69 Seeks Buyer 69 Boosts Profits 69 Announces Favorable Ruling 69 Reaches Settlement Agreement 69 Extends Expiration Date 69 H.B. Fuller 69 Stockholders Approve Acquisition 68 Files Bankruptcy 68 1Q Profit Slips 68 Billion Buyout 68 Files Patent Application 68 Aquires 68 Reverses Loss 68 2nd Quarter Results 68 Pending Acquisition 68 Enters Into License Agreement 68 Whistleblower Suit 68 Permanent Injunction Against 68 Posts 3Q Profit 68 Employment Inducement Awards 68 Withdraws Application 68 Terminates Contract 68 Reaffirms FY# EPS 68 Surpasses Expectations 68 3Q Profit Jumps 68 Premarket Movers 68 Q4 Profit Climbs 68 Announces License Agreement 68 Canaccord Genuity Reiterates Buy 68 Posts 2Q Loss 68 Nearly Triples 68 Announces Spin Off 68 1Q Profit Falls 68 FY# Loss Narrows 68 Commenced Against 68 Action Suit Against 68 Beats Expectations 68 Revamps Website 68 Stock Tumbles 68 3Q Profit Plunges 68 Be Bought 68 Posts Wider 4Q Loss 68 Receives Approvable Letter 68 3Q Profit Climbs 68 Anounces 68 Q1 Profit Drops 68 Q1 Profit Dips 68 Profit Dips 68 Sells Shares 68 Signs Licensing Agreement 68 Receives NASDAQ 68 FDA Clears 68 Delivers Solid 68 Q2 Profit Climbs 68 Lawsuit Settled 68 Faces Setback 68 CEO Exercises Options 68 Device Maker 68 Begins Shipment 68 Extends Offer 68 1Q Profit Down 68 Raises Quarterly Dividend 68 Buyout Offer 68 Boosts Quarterly Dividend 68 4Q Profit Jumps 68 Buy Privately Held 68 Maker Sues 68 File Sharing Case 68 Announces Tentative Approval 68 Completes Reverse Stock 68 Q1 Profit Declines 68 Infringed 68 Receives Unsolicited 68 Patent Infringements 68 Announces Cancellation 68 Approve Merger 68 Completes Financing 68 Suit Settled 68 Announces Stockholder Approval 68 Q4 Profit Decreases 68 3Q Profit Falls 68 Announces Share Buyback 68 Spins Off 68 Lowers Outlook 68 Narrows 1Q 68 Terminate Agreement 68 Bearish MACD 68 Files Patent Infringement Suit 68 REUTERS Mick Tsikas 68 4Q Profit Slips 68 Profit Exceeds Estimates 68 4Q Profit Slides 68 Suit Alleging 68 Secures Patent 68 Tops Estimate 68 Profits Plunge 68 4Q Profit Falls 68 Shareholders Approve Acquisition 68 Maximize Shareholder Value 68 Subsidiary Enters 68 #.#B Bid 68 Third Quarter Loss Widens 68 DR Horton Swings 68 Profit Triples 68 Jury Verdict 68 Delays Filing Annual Report 68 Sign Licensing Agreement 68 4Q Profit Dips 68 Mutually Agree 68 Discontinues 68 Reports Narrower 68 Posts 4Q 68 Meets Estimates 68 RealMoney Radio Mailbag 68 Weight Loss Drug 68 REUTERS Ray Stubblebine 68 For Undisclosed Terms 68 Settle Antitrust 68 NewsBite Downgrade Puts Pressure 68 Quarterly Loss Widens 68 Enters Into Licensing Agreement 68 Earnings Cheat Sheet 68 Drops Suit 68 Pending Litigation 68 Amends Merger Agreement 68 Concludes Acquisition 68 Terminates Agreement 68 Patent Spat 68 Posts Smaller 68 1Q Profit Soars 68 Patent Reexamination 68 Acquire Assets 68 Q4 Adj 68 REUTERS Mario Anzuoni 68 reaffirms FY# outlook 68 Share Buybacks 68 Lowers Price 68 More Than Triples 68 Monetizes 68 Optimistic Outlook 68 Commercializes 68 Rejects Unsolicited 68 Bulks Up 68 Posts Solid 68 Slashes Guidance 68 Unsolicited Tender Offer 68 Announces Job Cuts 68 FY# Loss Widens 67 Settle Lawsuit Over 67 Begins Rollout 67 Stockholders Approve Merger Agreement 67 Updates Guidance 67 REUTERS Rick Wilking 67 False Advertising 67 Settle Suit 67 Issued Patent 67 Migraine Drug 67 Seeks Damages 67 Osteoporosis Drug 67 Boosts Share Buyback 67 Finalize Agreement 67 Receives Notice From 67 Extends Collaboration 67 #.#B Buyout [001] 67 Begins Shipping 67 Shareholders Approve Sale 67 FY# Guidance 67 Guides Above 67 Patient Enrollment 67 2Q Profit Soars 67 Million Verdict 67 Integra LifeSciences Announces 67 Milestone Payments 67 Share Buyback 67 Submits Application 67 Restructures Operations 67 Debuts Next Generation 67 Private Equity Financing 67 Cholesterol Drug 67 Share Buyback Plan 67 Breakup Fee 67 Completes Enrollment 67 Aftermarket Movers 67 Mylan Receives Approval 67 Increases Size 67 Net Loss Narrows 67 Shareholders Approve Merger 67 Nasdaq Notice Regarding 67 Announce Expiration 67 Bearish Speculation 67 Enters Oversold Territory 67 Reach Settlement Agreement 67 Cuts Costs 67 Files Resale 67 Increases Share Repurchase 67 Unveils Newest 67 Posts Strong 67 Receives Milestone Payment 67 Successfully Closes 67 Beats Views 67 Distribution Pact 67 4Q Profit Drops 67 Nanophase Announces 67 #M Stock Buyback 67 3Q Profit Rises 67 Antitrust Complaint 67 FDA Approvals 67 Sinks Lower 67 Dividend Quick Facts 67 3Q Profit Down 67 Completes Restructuring 67 Beats Consensus 67 Announce Licensing Agreement 67 COO Exercises Options 67 Files Annual Report 67 Newly Introduced 67 Streamlines Operations 67 2Q Profit Climbs 67 Issues Clarification 67 Submits NDA 67 Complete Merger 67 Extend Partnership 67 Patent Infringement Claims 67 Gout Drug 67 Earnings Surge 67 REUTERS Danny Moloshok 67 FDA Accepts 67 Affirms Guidance 67 Announces Initiation 67 FY# EPS Forecast 67 Posts 3Q 67 Mad Money Mailbag 67 Q4 Profit Jumps 67 Winmark Corporation Announces 67 Has Spiked 67 More Than Quadruples 67 Restate Financial 67 Withdraw Plea 67 3Q Profit Drops 67 Refocuses 67 Announces Effectiveness 67 Backs FY# Forecast 67 Postpones Annual Meeting 67 Completes Buyout 67 2Q Profit Slips 67 Lawsuit Settlement 67 Regains Compliance With 67 Raises Bid 67 Scoops Up 67 Completes Redemption 67 Sexual Harassment Suit 67 Attorneys Fees 67 2Q Profit Drops 67 Guides Q2 67 Misses Expectations 67 Buys Majority Stake 67 Pending Merger 67 Redesigned Website 67 Launches Redesigned Website 67 Misses Estimate 67 Beating Estimates 67 Revises Third Quarter 67 Enhances User Experience 67 Achieves Record Sales 67 Deliberations Resume 67 2Q Profit Down 67 Shares Climb 67 Sweetens Bid 67 Reports 4Q Loss 67 Settle Probe 67 Shares Surge 67 Announces Proposed Settlement 67 Profit Slips 67 Explores Options 67 Q2 Profit Declines 67 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 67 Completes Purchase Of 67 Nasdaq Deficiency Notice 67 Raises Guidance 67 Starts Shipping 67 Wizzard Software Announces 67 Revenues Decline 67 Tops Forecasts 67 REUTERS Nigel Roddis 67 3Q Loss Narrows 67 Wrongful Death Case 67 Announces Immediate Availability 67 Backdating Case 67 Files Patent Infringement Lawsuit 67 Restates Results 67 Shareholder Investigation 67 Clarifies Status 67 Resolve Dispute 67 2Q Profit Falls 67 Narrows 3Q 67 Sets Annual Meeting 67 Declared Effective 67 3Q Profit Surges 67 Welcomes Analyst Initiation 67 Changes Ticker Symbol 67 Accounting Errors 67 Surpasses Estimates 67 IPhone App 67 Receives Patent 67 Files Motion 67 Settles Lawsuit 67 Announces Effective Date 67 Extend Contract 67 Resolves Litigation 67 Update# 67 Settle Lawsuit 67 Earns Milestone Payment 67 Seeks Injunction 67 EPS Tops Estimate 67 Achieves Milestone 67 Secures Additional 67 #.#/Share [002] 67 Financing Commitment 67 Receives Delisting Notice 67 Increases Buyback 67 Announces Organizational Changes 67 Complaint Against 67 REUTERS Stefan Wermuth 67 Derivative Lawsuit 67 Profit Doubles 67 Slashes Jobs 67 Completes Reorganization 67 1Q Profit Doubles 67 Announces Profitable 67 Shelf Registration 67 Terminate Merger 67 Provides Clarification 66 Announces Stock Buyback 66 #.#B Buyout [003] 66 Tentative Settlement 66 Finalizes Purchase 66 Guides FY# Earnings 66 Q4 Profit Declines 66 Upcoming Deadline 66 Taglich Brothers Initiates Coverage 66 IND Filing 66 Voluntarily Withdraw 66 3Q Profit Dips 66 Share Issuance 66 Sniper Suspect Trial 66 Seeks Approval 66 Exec Sees 66 Results Disappoint 66 Nasdaq Delisting Notification 66 Debt Refinancing 66 Shuffles Execs 66 Director Exercises Options 66 XTend Medical XMDC 66 Restate Earnings 66 Commences Mailing 66 Beats Raises Guidance 66 Discrimination Suit Against 66 3Q Profit Slips 66 Files Definitive Proxy 66 Amends Terms 66 Awarded Patent 66 Spins Out 66 DVD Copying 66 Enters Into Exclusive 66 Rejects Buyout Offer 66 Settles Patent Suit 66 Guides FY# FY# 66 Declares Bankruptcy 66 Guides Below 66 Enters Into Settlement Agreement 66 Obtains Exclusive License 66 Creditor Protection 66 Nears Launch 66 Stays Neutral 66 Discrimination Lawsuit 66 Updates Status 66 Completes Transaction 66 Announces Underwriters Exercise 66 Wider Than Expected 66 Denies Bid 66 Shareholder Claims 66 Lung Cancer Drug 66 1Q Profit Drops 66 Closing Arguments Heard 66 Announce Collaboration Agreement 66 Reaches Tentative Settlement 66 Found Liable 66 Slashes Prices 66 Option Grants 66 Refile 66 Antitrust Case 66 Patent Validity 66 Epilepsy Drug 66 Completes Private Placement 66 Announces Repurchase 66 Key Milestones 66 Sews Up 66 Fourth Quarter Profit Drops 66 Revises Guidance 66 Citi Downgrades 66 Reaffirms FY# Revenue 66 Margin Expansion 66 Wins Dismissal 66 REUTERS Kiyoshi Ota 66 Gets Favorable Ruling 66 Wins Lawsuit Against 66 Amends Credit 66 Expands Portfolio 66 1Q Profit Jumps 66 Announces Consummation 66 Million Shelf Registration 66 Guidance Quick Facts 66 Collaborates With 66 Increases Guidance 66 Updates FY# EPS 66 Boosts Forecast 66 Profit Sinks 66 CFO Exercises Options 66 Settles Patent Infringement Lawsuit 66 ANDRE FORGET QMI Agency 66 Q2 Profit Jumps 66 1Q Profit Surges 66 Lowers Forecast 66 Mulls Sale 66 Expects 1Q 66 FY# Profit Declines 66 Profits Climb 66 Univest Corporation Declares 66 Narrows 2Q 66 Reports Significantly Improved 66 Quarterly Loss Narrows 66 Reports Narrower Loss 66 Claim Filed 66 Asset Swap 66 1Q Profit Rises 66 Unsolicited Proposal 66 Q3 Profit Declines 66 Wins Injunction Against 66 Develop Next Generation 66 Announces Recapitalization 66 Ups Ante 66 Lags Estimates 66 TiVo Posts Narrower 66 Quarterly Earnings Release 66 Delivers Next Generation 66 Achieves Significant 66 Announces Shareholder Approval 66 Completes Acquisitions 66 PPD Declares 66 Declares Dividend Increase 66 2Q Profit 66 Previously Announced Private Placement 66 Stock Repurchase Authorization 66 Wins Approval 66 4Q Loss Narrows 66 4Q Loss 66 Initiates Enrollment 66 Bumps Up 66 Renews Expands 66 Profit Leaps 66 Calls Purchased 66 3Q Profit Soars 66 Investigates Proposed Acquisition 66 Drug Coated Stent 66 Renegotiates 66 Tops Views 66 Inks Licensing Deal 66 Announces Restatement 66 Inks Deals 66 3rd Quarter Results 66 Copyright Infringement Lawsuit 66 Antitrust Suit Against 66 NASDAQ Delisting 66 &Amp; 66 Reacquires 66 Earnings Postmortem 66 Suits Against 66 Underwriters Exercise Over Allotment 66 Beats Forecasts 66 Earnings Disappoint 66 ONN.tv Report 66 Exceeds Estimates 66 Daytradersdigest.com 66 2Q Profit Up 66 REUTERS Fred Prouser 66 Announces Reverse Split 66 Much Awaited 66 Bankruptcy Reorganization 66 Miraculins Announces 66 Analyst Predicts 66 Investigation Relating 66 2Q Profit Dips 66 Sexual Harassment Case 66 Earnings Climb 66 Q3 Profit Climbs 66 Closes Acquisition Of 66 Q1 Profit Slips 66 FDA Okays 66 3Q Profit Up 66 Wrongful Death Lawsuit 66 Seeks Dismissal Of 66 Dramatically Expands 66 Confirms Receipt 66 Fee Dispute 66 Enters Into Joint Venture 66 Completes Merger 66 REUTERS David Mdzinarishvili 66 Introduces Revolutionary 66 2Q Profit Doubles 66 Execs Plead Guilty 66 Announces Discontinuation 66 Above Consensus 66 Discrimination Lawsuit Against 66 RealMoney Radio Recap 66 Inhaled Insulin 66 Finalizes Sale 66 Tops Expectations 66 StockProfiler.US Stock Profiler.US 66 Wi Fi Enabled 66 1Q Profit Up 66 Q3 Profit Slips 66 Posts Better Than 66 Posts Loss 66 Holders Approve 66 Jointly Announce 66 Slims Down 66 Above Estimates 66 Officially Released 66 No. #-# Fed. 66 4Q Profit Doubles 66 Awarded Patents 66 3Q Loss 66 Hits Milestone 66 Doubles Capacity 66 ISSI Announces 66 2Q Profit Jumps 66 Below Estimates 66 ZTEST Announces 66 XPEL Announces 66 Undisclosed Amount 66 FTC Clears 66 Underwritten Public 66 Completes Transition 66 Tops Ests 66 Shareholder Sues 66 4Q Profit Rises 66 Boosts Stake 66 VP Exercises Options 66 Q4 Profit Rises 66 Completes Previously Announced 66 Billion Share Buyback 66 Announces Adjournment 66 Million Share Buyback 66 Announces Stock Repurchase 66 Reduces Size 66 Paternity Suit 66 Below Consensus 66 Q1 Profit Climbs 66 Quadruples 66 Whistleblower Lawsuit 66 Movers Roundup 66 Enters Joint Venture 66 Files Shelf Registration 66 Generic Versions 66 Announces Enhancements 65 Inc. LATEST NEWS 65 Travolta Extortion Case 65 Licenses Patents 65 Posts Profit 65 Doctor Testifies 65 Achieves Positive 65 Settles FTC 65 Announces Postponement 65 Wrongful Death Suit 65 Closing Arguments Set 65 Guides FY# 65 Unveils Groundbreaking 65 Successfully Defends 65 Increases Quick Facts 65 Posts Wider 65 Noven Pharma 65 Secures Long Term 65 Acquire Privately Held 65 Closes Financing 65 REUTERS Jeff Zelevansky 65 Begins Tender Offer 65 Seek Shareholder Approval 65 Raises Outlook 65 Gets Upgraded 65 Continues Climb 65 Earnings Decline 65 Announces Termination 65 Canaccord Genuity Maintains Hold 65 Profit Soars 65 Leaps Ahead 65 Avoids Trial 65 Ventures Invests 65 Verdict Upheld 65 Misled Investors 65 4Q Profit Up 65 Authorizes Additional 65 Guides Q4 65 Million Buyback 65 Stem Cell Patents 65 SVP Exercises Options 65 Posts Wider 2Q 65 Dismiss Suit 65 Puts Purchased 65 Reduces Workforce 65 Amplifies 65 Files Quarterly Report 65 Underwriters Over Allotment 65 Profit Misses Estimates 65 Anticipates Strong 65 Quick Facts2 65 Acquire Remaining Shares 65 Post Earnings Checkup 65 Completes Sale Of 65 Loses Lawsuit 65 Provides Updates 65 Merge Healthcare Announces 65 Posts 1Q 65 Lawsuits Filed 65 Announces Record Date 65 Extends Maturity 65 Found Competent 65 Unveils Revolutionary 65 Schizophrenia Drug 65 Gobbles Up 65 NASDAQ Deficiency Notice 65 Results Exceed Expectations 65 1Q Profit Climbs 65 PROFILE CO 65 Provides Guidance 65 Copyright Infringement Case 65 Approves Share Repurchase 65 Settle Dispute Over 65 Shares Tumble 65 Appeal Denied 65 Downsizes 65 Common Share Repurchase Program 65 Deregister 65 4Q Profit Plunges 65 Inc. Endures Analyst 65 Completes Initial 65 REUTERS Gary Hershorn 65 Activity Alert 65 Regains Compliance 65 Declares Regular Cash Dividend 65 Record Third Quarter 65 Store Closings 65 Planned Acquisition 65 Files Registration Statement 65 Introduces Enhanced 65 Revises FY# 65 Million Settlement Reached 65 1Q Loss 65 Share Buyback Program 65 Countersues 65 Unveils Expanded 65 Manslaughter Charge 65 Formally Launches 65 Reports 2Q Profit 65 Refinances Debt 65 Share Repurchases 65 Unveils Next Generation 65 Jury Verdict Against 65 Higher Margins 65 Shelf Registration Statement 65 Sets Record Date 65 FCC Approves 65 Patent Upheld 65 Profit Beats Estimates 65 Subsidiary Files 65 Prostate Cancer Vaccine 65 Loss Widens 65 Receives Permission 65 REUTERS Carlos Barria 65 Evergreen Closed End 65 Bullish Speculation 65 4th Qtr Profit Rises 65 Shareholder Derivative 65 Receive Milestone Payment 65 Entered Into 65 REUTERS Jim Ruymen 65 4Q Profit Tumbles 65 Profit Tops Estimates 65 Teva Provides Update 65 Delay Filing 65 Resubmit 65 Immunomedics Announces